Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

The clinical significance and primary determinants of hirsutism in patients with polycystic ovary syndrome.

Panidis D, Tziomalos K, Papadakis E, Chatzis P, Kandaraki EA, Tsourdi EA, Vosnakis C, Katsikis I.

Eur J Endocrinol. 2013 May 3;168(6):871-7. doi: 10.1530/EJE-13-0039. Print 2013 Jun.

PMID:
23557988
2.

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI.

J Clin Endocrinol Metab. 1999 Nov;84(11):4006-11.

PMID:
10566641
3.

Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.

Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A.

Exp Clin Endocrinol Diabetes. 2007 Jun;115(6):380-6.

PMID:
17701884
4.

Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.

Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W.

J Cosmet Dermatol. 2018 Jun;17(3):511-517. doi: 10.1111/jocd.12387. Epub 2017 Sep 21.

PMID:
28940857
5.

Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.

Schmidt TH, Khanijow K, Cedars MI, Huddleston H, Pasch L, Wang ET, Lee J, Zane LT, Shinkai K.

JAMA Dermatol. 2016 Apr;152(4):391-8. doi: 10.1001/jamadermatol.2015.4498.

PMID:
26720591
6.

Degree of hyperinsulinemia, independent of androgen levels, is an important determinant of the severity of hirsutism in PCOS.

Landay M, Huang A, Azziz R.

Fertil Steril. 2009 Aug;92(2):643-7. doi: 10.1016/j.fertnstert.2008.06.021. Epub 2008 Aug 22.

8.

Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.

Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A, Giordano C.

Eur J Endocrinol. 2006 Dec;155(6):859-65.

PMID:
17132756
9.

High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus.

Escobar-Morreale HF, Roldán B, Barrio R, Alonso M, Sancho J, de la Calle H, García-Robles R.

J Clin Endocrinol Metab. 2000 Nov;85(11):4182-7.

PMID:
11095451
10.

Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women.

Coskun A, Ercan O, Arikan DC, Özer A, Kilinc M, Kiran G, Kostu B.

Eur J Obstet Gynecol Reprod Biol. 2011 Feb;154(2):167-71. doi: 10.1016/j.ejogrb.2010.10.001. Epub 2010 Nov 1.

PMID:
21041013
11.

Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women.

Liou TH, Yang JH, Hsieh CH, Lee CY, Hsu CS, Hsu MI.

Fertil Steril. 2009 Dec;92(6):1960-5. doi: 10.1016/j.fertnstert.2008.09.003. Epub 2008 Nov 5.

PMID:
18980763
13.

Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity.

Nácul AP, Andrade CD, Schwarz P, de Bittencourt PI Jr, Spritzer PM.

Eur J Obstet Gynecol Reprod Biol. 2007 Aug;133(2):191-6. Epub 2006 Oct 17.

PMID:
17049715
14.

Acne severity and the Global Acne Grading System in polycystic ovary syndrome.

Hacivelioglu S, Gungor AN, Gencer M, Uysal A, Hizli D, Koc E, Cosar E.

Int J Gynaecol Obstet. 2013 Oct;123(1):33-6. doi: 10.1016/j.ijgo.2013.05.005. Epub 2013 Aug 12.

PMID:
23948280
15.

Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index.

Alexiou E, Hatziagelaki E, Pergialiotis V, Chrelias C, Kassanos D, Siristatidis C, Kyrkou G, Kreatsa M, Trakakis E.

Horm Mol Biol Clin Investig. 2017 Mar 1;29(3):105-111. doi: 10.1515/hmbci-2016-0047.

PMID:
28099123
16.

Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.

Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F.

Medicine (Baltimore). 2009 Jan;88(1):32-45. doi: 10.1097/md.0b013e3181946a2c.

17.

Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.

Meczekalski B, Slopien R, Warenik-Szymankiewicz A.

Eur J Obstet Gynecol Reprod Biol. 2007 May;132(1):88-92. Epub 2006 Sep 18.

PMID:
16979812
18.

CAG repeat polymorphism in androgen receptor gene is not directly associated with polycystic ovary syndrome but influences serum testosterone levels.

Skrgatic L, Baldani DP, Cerne JZ, Ferk P, Gersak K.

J Steroid Biochem Mol Biol. 2012 Feb;128(3-5):107-12. doi: 10.1016/j.jsbmb.2011.11.006. Epub 2011 Nov 17.

PMID:
22107839
19.

[Study on the facial and body terminal hair growth in women in Guangdong by using modified Ferriman-Gallwey scoring system].

Zhao XM, Ni RM, Huang J, Huang LL, Du SM, Ma MJ, Lin DY, Yang DZ.

Zhonghua Fu Chan Ke Za Zhi. 2013 Jun;48(6):427-31. Chinese.

PMID:
24103121
20.

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

Asunción M, Calvo RM, San Millán JL, Sancho J, Avila S, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2000 Jul;85(7):2434-8.

Supplemental Content

Support Center